HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2020 | 4143 | 4609 | 89.9% | |
| HF006 | 2021 | 7314 | 8357 | 87.5% | |
| HF006 | 2022 | 8774 | 9360 | 93.7% | |
| HF006 | 2023 | 10339 | 11025 | 93.8% |
